Programme started: March 2012
Programme ended: December 2016
Total programme cost: $4.12 million
Crown funding paid out : $2.04 million
Estimated economic benefits to NZ: $5 million to $16.4 million a year by 2021
Commercial partners: Wairarapa Moana ki Pouakani Incorporation, Miraka Ltd, Kanematsu New Zealand Ltd.
Whai Hua programme outcomes include:
- development of a skim milk powder (SMP) product with high levels of a natural immune-enhancing compound
- research indicating that the target compound in cow's milk acts in a similar way to its counterpart in human milk, binding with a wide range of bacteria
- research showing that SMP with higher levels of the target compound, lower infection levels of pathogenic bacteria in the gut of mice
- an elite herd of 510 cows with naturally high levels of the target compound, and a standard operating procedure developed to increase the herd.
Outcome Logic Model
- Outcome logic model for Whai Hua [PDF, 99 KB]
Final programme reports
Background to the programme
For a long time, the New Zealand dairy industry has supplied dairy ingredients for food manufacture. The challenge now is to develop new, value-added ingredients, working closely with market partners.
For Whai Hua, there was an added challenge to create a niche for themselves and an opportunity to develop Māori agribusiness capability.
The Whai Hua solution
The Whai Hua PGP programme aimed to develop immune-enhancing dairy milk products, targeting health-conscious consumers in Asia and New Zealand.
Audit and progress reports
- Audit - Whai Hua [PDF, 540 KB]
- Progress review summary report - Whai Hua [PDF, 805 KB]
- Quarterly progress report summaries - Whai Hua